Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- SARS-CoV-2
- Sponsor
- University Hospital, Strasbourg, France
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients
- Last Updated
- 5 years ago
Overview
Brief Summary
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population
Investigators
Eligibility Criteria
Inclusion Criteria
- •All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection
- •Adult and pediatric
Exclusion Criteria
- •There are no exclusion criteria, except for the patient's explicit refusal to participate
Outcomes
Primary Outcomes
Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients
Time Frame: From 1st March 2020 to 1st March 2021